Early Detection of Underlying Cavernomas in Patients with Spontaneous Acute Intracerebral Hematomas

References

1. 1.↵
   1. Gross BA,
   2. Jankowitz BT,
   3. Friedlander RM

   . Cerebral intraparenchymal hemorrhage: a review. JAMA 2019;321:1295–303 doi:10.1001/jama.2019.2413 pmid:30938800

   CrossRefPubMed
2. 2.↵
   1. Kamel H,
   2. Navi BB,
   3. Hemphill JC 3rd.

   A rule to identify patients who require magnetic resonance imaging after intracerebral hemorrhage. Neurocrit Care 2013;18:59–63 doi:10.1007/s12028-011-9607-7 pmid:21761271

   CrossRefPubMed
3. 3.↵
   1. Salmela MB,
   2. Mortazavi S,
   3. Jagadeesan BD, et al

   ; Expert Panel on Neurologic Imaging. ACR Appropriateness Criteria Cerebrovascular Disease. J Am Coll Radiol 2017;14:S34–61 doi:10.1016/j.jacr.2017.01.051 pmid:28473091

   CrossRefPubMed
4. 4.↵
   1. Morotti A,
   2. Boulouis G,
   3. Dowlatshahi D, et al

   ; International NCCT ICH Study Group. Standards for detecting, interpreting, and reporting noncontrast computed tomographic markers of intracerebral hemorrhage expansion. Ann Neurol 2019;86:480–92 doi:10.1002/ana.25563 pmid:31364773

   CrossRefPubMed
5. 5.↵
   1. Delcourt C,
   2. Zhang S,
   3. Arima H, et al

   ; INTERACT2 Investigators. Significance of hematoma shape and density in intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Intracerebral Hemorrhage Trial study. Stroke 2016;47:1227–32 doi:10.1161/STROKEAHA.116.012921 pmid:27073236

   Abstract/FREE Full Text
6. 6.↵
   1. Rodrigues MA,
   2. Samarasekera N,
   3. Lerpiniere C, et al

   . The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol 2018;17:232–40 doi:10.1016/S1474-4422(18)30006-1 pmid:29331631

   CrossRefPubMed
7. 7.↵
   1. Mottolese C,
   2. Hermier M,
   3. Stan H, et al

   . Central nervous system cavernomas in the pediatric age group. Neurosurg Rev 2001;24:55–71; discussion 72–73 doi:10.1007/pl00014581 pmid:11485241

   CrossRefPubMed
8. 8.↵
   1. Kurihara N,
   2. Suzuki H,
   3. Kato Y, et al

   . Hemorrhage owing to cerebral cavernous malformation: imaging, clinical, and histopathological considerations. Jpn J Radiol 2020;38:613–21 doi:10.1007/s11604-020-00949-x pmid:32221793

   CrossRefPubMed
9. 9.↵
   1. Zabramski JM,
   2. Wascher TM,
   3. Spetzler RF, et al

   . The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg 1994;80:422–32 doi:10.3171/jns.1994.80.3.0422 pmid:8113854

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Kranz PG,
    2. Malinzak MD,
    3. Amrhein TJ

    . Approach to imaging in patients with spontaneous intracranial hemorrhage. Neuroimaging Clin N Am 2018;28:353–74 doi:10.1016/j.nic.2018.03.003 pmid:30007750

    CrossRefPubMed
11. 11.↵
    1. Rindler RS,
    2. Allen JW,
    3. Barrow JW, et al

    . Neuroimaging of intracerebral hemorrhage. Neurosurgery 2020;86:E414–23 doi:10.1093/neuros/nyaa029 pmid:32109294

    CrossRefPubMed
12. 12.↵
    1. Tomlinson FH,
    2. Houser OW,
    3. Scheithauer BW, et al

    . Angiographically occult vascular malformations: a correlative study of features on magnetic resonance imaging and histological examination. Neurosurgery 1994;34:792–99; discussion 799–800 doi:10.1227/00006123-199405000-00002 pmid:8052376

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Frischer JM,
    2. Pipp I,
    3. Stavrou I, et al

    . Cerebral cavernous malformations: congruency of histopathological features with the current clinical definition. J Neurol Neurosurg Psychiatry 2008;79:783–88 doi:10.1136/jnnp.2007.132316 pmid:17986498

    Abstract/FREE Full Text
14. 14.↵
    1. Flemming KD,
    2. Kumar S,
    3. Lanzino G, et al

    . Baseline and evolutionary radiologic features in sporadic, hemorrhagic brain cavernous malformations. AJNR Am J Neuroradiol 2019;40:967–72 doi:10.3174/ajnr.A6076 pmid:31097428

    Abstract/FREE Full Text
15. 15.↵
    1. Fazekas F,
    2. Barkhof F,
    3. Wahlund LO, et al

    . CT and MRI rating of white matter lesions. Cerebrovasc Dis 2002;13(Suppl 2):31–36 doi:10.1159/000049147 pmid:11901240

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Webb AJ,
    2. Ullman NL,
    3. Morgan TC, et al

    ; MISTIE and CLEAR Investigators. Accuracy of the ABC/2 score for intracerebral hemorrhage: systematic review and analysis of MISTIE, CLEAR-IVH, and CLEAR III. Stroke 2015;46:2470–76 doi:10.1161/STROKEAHA.114.007343 pmid:26243227

    Abstract/FREE Full Text
17. 17.↵
    1. Breiman L,
    2. Friedman JH,
    3. Olshen RA, et al

    . Classification and Regression Trees. Routledge; 2017
18. 18.↵
    1. Boulouis G,
    2. Blauwblomme T,
    3. Hak JF, et al

    . Nontraumatic pediatric intracerebral hemorrhage. Stroke 2019;50:3654–61 doi:10.1161/STROKEAHA.119.025783 pmid:31637968

    CrossRefPubMed
19. 19.↵
    1. Goldstein HE,
    2. Solomon RA

    . Epidemiology of cavernous malformations. Handb Clin Neurol 2017;143:241–47 doi:10.1016/B978-0-444-63640-9.00023-0 pmid:28552146

    CrossRefPubMed
20. 20.↵
    1. Barras CD,
    2. Tress BM,
    3. Christensen S, et al

    ; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Density and shape as CT predictors of intracerebral hemorrhage growth. Stroke 2009;40:1325–31 doi:10.1161/STROKEAHA.108.536888 pmid:19286590

    Abstract/FREE Full Text
21. 21.↵
    1. Zabramski JM,
    2. Henn JS,
    3. Coons S

    . Pathology of cerebral vascular malformations. Neurosurg Clin N Am 1999;10:395–410 doi:10.1016/S1042-3680(18)30174-8 pmid:10419567

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Abe M,
    2. Fukudome K,
    3. Sugita Y, et al

    . Thrombus and encapsulated hematoma in cerebral cavernous malformations. Acta Neuropathol 2005;109:503–09 doi:10.1007/s00401-005-0994-8 pmid:15759126

    CrossRefPubMed
23. 23.↵
    1. Cordonnier C,
    2. Al-Shahi Salman R,
    3. Bhattacharya JJ,et al

    ; SIVMS Collaborators. Differences between intracranial vascular malformation types in the characteristics of their presenting haemorrhages: prospective, population-based study. J Neurol Neurosurg Psychiatry 2008;79:47–51 doi:10.1136/jnnp.2006.113753 pmid:17488785

    Abstract/FREE Full Text
24. 24.↵
    1. Ellis JA,
    2. Barrow DL

    . Supratentorial cavernous malformations. Handb Clin Neurol 2017;143:283–89 doi:10.1016/B978-0-444-63640-9.00027-8 pmid:28552151

    CrossRefPubMed
25. 25.↵
    1. Steiger HJ,
    2. Markwalder TM,
    3. Reulen HJ

    . Clinicopathological relations of cerebral cavernous angiomas: observations in eleven cases. Neurosurgery 1987;21:879–84 doi:10.1227/00006123-198712000-00016 pmid:3325850

    CrossRefPubMed
26. 26.↵
    1. Little JR,
    2. Awad IA,
    3. Jones SC, et al

    . Vascular pressures and cortical blood flow in cavernous angioma of the brain. J Neurosurg 1990;73:555–59 doi:10.3171/jns.1990.73.4.0555 pmid:2398387

    CrossRefPubMed
27. 27.↵
    1. Flemming KD,
    2. Lanzino G

    . Cerebral cavernous malformation: what a practicing clinician should know. Mayo Clin Proc 2020;95:2005–20 doi:10.1016/j.mayocp.2019.11.005 pmid:32605781

    CrossRefPubMed
28. 28.↵
    1. Sze G,
    2. Krol G,
    3. Olsen WL, et al

    . Hemorrhagic neoplasms: MR mimics of occult vascular malformations. AJR Am J Roentgenol 1987;149:1223–30 doi:10.2214/ajr.149.6.1223 pmid:3500614

    CrossRefPubMed
29. 29.↵
    1. Kumar S,
    2. Brinjikji W,
    3. Lanzino G, et al

    . Distinguishing mimics from true hemorrhagic cavernous malformations. J Clin Neurosci 2020;74:11–17 doi:10.1016/j.jocn.2020.01.070 pmid:31982281

    CrossRefPubMed
30. 30.↵
    1. Nishiyama A,
    2. Toi H,
    3. Takai H, et al

    . Chronic encapsulated intracerebral hematoma: three case reports and a literature review. Surg Neurol Int 2014;5:88 doi:10.4103/2152-7806.134076 pmid:25024888

    CrossRefPubMed
31. 31.↵
    1. Taslimi S,
    2. Modabbernia A,
    3. Amin-Hanjani S, et al

    . Natural history of cavernous malformation: systematic review and meta-analysis of 25 studies. Neurology 2016;86:1984–91 doi:10.1212/WNL.0000000000002701 pmid:27164680

    Abstract/FREE Full Text
32. 32.↵
    1. Horne MA,
    2. Flemming KD,
    3. Su IC, et al

    ; Cerebral Cavernous Malformations Individual Patient Data Meta-analysis Collaborators. Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data. Lancet Neurol 2016;15:166–73 doi:10.1016/S1474-4422(15)00303-8 pmid:26654287

    CrossRefPubMed
33. 33.↵
    1. Akers A,
    2. Al-Shahi Salman R,
    3. Awad AI, et al

    . Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery 2017;80:665–80 doi:10.1093/neuros/nyx091 pmid:28387823

    CrossRefPubMed
34. 34.↵
    1. Awad IA,
    2. Polster SP

    . Cavernous angiomas: deconstructing a neurosurgical disease. J Neurosurg 2019;131:1–13 doi:10.3171/2019.3.JNS181724 pmid:31261134

    CrossRefPubMed
35. 35.↵
    1. Idiculla PS,
    2. Gurala D,
    3. Philipose J, et al

    . Cerebral cavernous malformations, developmental venous anomaly, and its coexistence: a review. Eur Neurol 2020;83:360–68 doi:10.1159/000508748 pmid:32731220

    CrossRefPubMed